BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Pharm Country

  Cellectis to Present Data at the 2018 ASGCT Annual Meeting

  Cellectis to Present Data at the 2018 ASGCT Annual Meeting

  May 10, 2018

   · 

  4 min read
• BioCapital

  Global Virus Network Issues Open Letter to WHO On Potent Human Carcinogen - Human T Cell Leukemia Virus-1

  Lancet publishes letter from top scientists and advocates from around the world to eradicate HTLV-1, a debilitating and deadly virus

  May 10, 2018

   · 

  7 min read
• Business

  GBT Reports First Quarter 2018 Results

  DOUBLE-DIGIT REVENUE AND EBITDA GROWTH. ALL MARGINS IMPROVING SIGNIFICANTLY. NEW PRODUCTS LAUNCHES AHEAD OF PLAN. EXTENDED PARTNERSHIP WITH GILEAD INTO ANDEAN REGION.

  May 10, 2018

   · 

  1 min read
• Business

  Alliar Annouces 1Q18 Results

  Centro de Imagem Diagnósticos S.A. (“Alliar” or “Company”) (B3: AALR3), announces today its results for the first quarter of 2018 (1Q18).

  May 10, 2018

   · 

  1 min read
• Business

  TissueTech Appoints Dr. Frank Young Executive Vice President of Regulatory Affairs

  TissueTech Inc., pioneers of the development and clinical application of amniotic tissue-based products, announced today the appointment of Dr. Frank Young as Executive Vice President of Regulatory Affairs.

  May 10, 2018

   · 

  2 min read
• Business

  Sierra Oncology Reports First Quarter Results

  $133.8 million cash expected to fund programs through approximately mid-2020

  May 10, 2018

   · 

  14 min read
• Business

  RXi Pharmaceuticals Reports First Quarter 2018 Financial Results and Recent Corporate Highlights

  Reduced cash burn per quarter by 20% from $2.5 million to $2 million

  May 10, 2018

   · 

  12 min read
• Business

  Arsanis Reports Business Highlights and Financial Results for First Quarter 2018

  ASN100 Phase 2 Trial Interim Analysis Results Expected in Late June

  May 10, 2018

   · 

  9 min read
• Biotech Bay

  Centers for Medicare and Medicaid Services Approves Reimbursement for BioCardia’s CardiAMP Cell Therapy in Pivotal Clinical Trial Studying Second Indication in Chronic Myocardial Ischemia

  Medicare reimbursement in the pivotal trial of the CardiAMP Cell Therapy System significantly enhances the Company’s ability to complete this important trial

  May 10, 2018

   · 

  6 min read
• Business

  Syros Reports First Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

  Presented Preclinical Data on SY-1365 Showing Potent Anti-Tumor Activity in Multiple Models of Heavily Pretreated Ovarian Cancer

  May 10, 2018

   · 

  10 min read